Reducing overuse of cervical cancer screening: A systematic review

Preventive Medicine

Volumn 116, Issue , 2018, Pages 51-59

  Alber, Julia M ^a,f   Brewer, Noel T ^b   Melvin, Cathy ^c   Yackle, Alyssa ^a,g   Smith, Jennifer S ^b   Ko, Linda K ^d   Crawford, Anatasha ^e,h   Glanz, Karen ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^f CALIFORNIA POLYTECHNIC STATE UNIVERSITY   (United States)

^g Society of Clinical Research Associates   (United States)

^h TRM Oncology   (United States)

Author keywords

Appropriate use; Cancer screening; Overuse; Pap tests; Quality of care

Indexed keywords

AGE; ATTITUDE TO ILLNESS; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; CLINICAL EFFECTIVENESS; CORRELATIONAL STUDY; DIAGNOSTIC ERROR; HUMAN; HYSTERECTOMY; MARRIAGE; MEDICAL PRACTICE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; EARLY CANCER DIAGNOSIS; FEMALE; HEALTH SERVICE; PREVENTIVE HEALTH SERVICE; PROCEDURES; UTERINE CERVIX TUMOR;

EARLY DETECTION OF CANCER; FEMALE; HUMANS; MEDICAL OVERUSE; PREVENTIVE HEALTH SERVICES; UTERINE CERVICAL NEOPLASMS;

EID: 85054128617     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2018.08.027     Document Type: Review

References (56)

1. Allen, J.D., Bluethmann, S.M., Sheets, M., Opdyke, K.M., Gates-Ferris, K., Hurlbert, M. et al., Women's responses to changes in U.S. Preventive Task Force's mammography screening guidelines: results of focus groups with ethnically diverse women. BMC Public Health, 13, 2013, 1169.
2. Almeida, C.M., Rodriguez, M.A., Skootsky, S., Pregler, J., Steers, N., Wenger, N.S., Cervical cancer screening overuse and underuse: patient and physician factors. Am. J. Manag. Care 19:6 (2013), 482–489.
3. American Cancer Society, The American Cancer Society guidelines for the prevention and early detection of cervical cancer 2016. Available from https://www.cancer.org/cancer/cervical-cancer/prevention-and-early-detection/cervical-cancer-screening-guidelines.html.
4. Arbyn, M., Quataert, P., Van Hal, G., Van Oyen, H., Cervical cancer screening in the Flemish region (Belgium): measurement of the attendance rate by telephone interview. Eur. J. Cancer Prev. 6:4 (1997), 389–398.
5. Arbyn, M., Fabri, V., Temmerman, M., Simoens, C., Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002–2006). PLoS One, 9(4), 2014, e92615.
6. Arrossi, S., Paolino, M., Sankaranarayanan, R., Challenges faced by cervical cancer prevention programs in developing countries: a situational analysis of program organization in Argentina. Rev. Panam. Salud Publica 28:4 (2010), 249–257.
7. Barbadoro, P., Ricciardi, A., Di Tondo, E., Vallorani, S., Mazzarini, G., Prospero, E., Utilization patterns of cervical cancer screening in Italy. Eur. J. Cancer Prev. 24:2 (2015), 135–140.
8. Berwick, D.M., Hackbarth, A.D., Eliminating waste in US health care. JAMA 307:14 (2012), 1513–1516.
9. Broach, V., Day, L., Barenberg, B., Huang, S., Kenton, K., White, P., Use of electronic health record-based tools to improve appropriate use of the human papillomavirus test in adult women. J. Low. Genit. Tract Dis. 18:1 (2014), 26–30.
10. Colla, C.H., Swimming against the current — what might work to reduce low-value care?. N. Engl. J. Med. 371:14 (2014), 1280–1283.
11. Elshaug, A.G., Watt, A.M., Mundy, L., Willis, C.D., Over 150 potentially low-value health care practices: an Australian study. Med. J. Aust., 197(10), 2012.
12. Frederiksen, M.E., Njor, S., Lynge, E., Rebolj, M., Psychological effects of diagnosis and treatment of cervical intraepithelial neoplasia: a systematic review. Sex. Transm. Infect. 91:4 (2015), 248–256.
13. Guo, F., Hirth, J.M., Berenson, A.B., Cervical cancer screening among women ≥70 years of age in the United States-a referral problem or patient choice. Prev. Med. 81 (2015), 427–432.
14. Gustafsson, L., Pontén, J., Zack, M., Adami, H.O., International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 8:5 (1997), 755–763.
15. Henderson, J.T., Harper, C.C., Gutin, S., Saraiya, M., Chapman, J., Sawaya, G.F., Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists. Am. J. Obstet. Gynecol. 208:2 (2013), 109.e1–109.e7.
16. Hills, R.L., Kulbok, P.A., Clark, M., Evaluating a quality improvement program for cervical cancer screening at an urban safety net clinic. Health Promot. Pract. 16:5 (2015), 631–641.
17. Hoffman, R.M., Lewis, C.L., Pignone, M.P., Couper, M.P., Barry, M.J., Elmore, J.G. et al., Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med. Decis. Mak. 30:5 Suppl (2010), 53S–64S.
18. Jha, A.K., Meaningful use of electronic health records: the road ahead. JAMA 304:15 (2010), 1709–1710.
19. Kale, M.S., Federman, A.D., Keyhani, S., Accurately estimating cervical cancer screening overuse among older women–reply. JAMA Intern. Med. 173:13 (2013), 1266–1267.
20. Kepka, D., Breen, N., King, J.B., Meissner, H.I., Roland, K.B., Benard, V.B. et al., Demographic factors associated with overuse of Pap testing. Am. J. Prev. Med. 47:5 (2014), 629–633.
21. King, N.R., Kasper, K.M., Daggy, J.K., Tucker, Edmonds B., Current practice patterns in cervical cancer screening in Indiana. Am. J. Obstet. Gynecol. 210:3 (2014), 265.e1–265.e8.
22. Korfage, I.J., van Ballegooijen, M., Wauben, B., Looman, C.W., Habbema, J.D., Essink-Bot, M.L., Having a pap smear, quality of life before and after cervical screening: a questionnaire study. BJOG 119:8 (2012), 936–944.
23. Li, J., Berkowitz, Z., Richards, T.B., Richardson, L.C., Shared decision making in prostate-specific antigen testing with men older than 70 years. J. Am. Board Fam. Med. 26:4 (2013), 401–408.
24. Makkonen, P., Heinavaara, S., Sarkeala, T., Anttila, A., Impact of organized and opportunistic Pap testing on the risk of cervical cancer in young women: case-control study from Finland. Gynecol. Oncol. 147:3 (2017), 601–606.
25. Marchand, L., Van Dinter, M., Mundt, M., Dingel, W., Klein, G., Current cervical cancer screening practices of Dane County, Wisconsin primary care clinicians. WMJ 102:3 (2003), 35–40.
26. McHugh, M.L., Interrater reliability: the kappa statistic. Biochem. Med. (Zagreb) 22:3 (2012), 276–282.
27. Meissner, H.I., Tiro, J.A., Haggstrom, D., Lu-Yao, G., Breen, N., Does patient health and hysterectomy status influence cervical cancer screening in older women?. J. Gen. Intern. Med. 23:11 (2008), 1822–1828.
28. Nayar, R., Goulart, R.A., Tiscornia-Wasserman, P.G., Davey, D.D., Primary human papillomavirus screening for cervical cancer in the United States-US Food and Drug Administration approval, clinical trials, and where we are today. Cancer Cytopathol. 122:10 (2014), 720–729.
29. Pelzang, R., Time to learn: understanding patient-centred care. Br. J. Nurs. 19:14 (2010), 912–917.
30. Perkins, R.B., Anderson, B.L., Gorin, S.S., Schulkin, J.A., Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists. Am. J. Prev. Med. 45:2 (2013), 175–181.
31. Prasad, V., Ioannidis, J.P.A., Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices. Implement. Sci., 9, 2014, 1.
32. Prasad, V., Vandross, A., Toomey, C., Cheung, M., Rho, J., Quinn, S. et al., A decade of reversal: an analysis of 146 contradicted medical practices. Mayo Clin. Proc. 88:8 (2013), 790–798.
33. Royce, T.J., Hendrix, L.H., Stokes, W.A., Allen, I.M., Chen, R.C., Cancer screening rates in individuals with different life expectancies. JAMA Intern. Med. 174:10 (2014), 1558–1565.
34. Salloum, R.G., Kohler, R.E., Jensen, G.A., Sheridan, S.L., Carpenter, W.R., Biddle, A.K., U.S. preventive services task force recommendations and cancer screening among female Medicare beneficiaries. J. Women's Health (Larchmt) 23:3 (2014), 211–217.
35. Salz, T., Gottlieb, S.L., Smith, J.S., Brewer, N.T., The association between cervical abnormalities and attitudes toward cervical cancer prevention. J. Women's Health 19:11 (2010), 2011–2016.
36. Saslow, D., Solomon, D., Lawson, H.W., Killackey, M., Kulasingam, S.L., Cain, J. et al., American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J. Clin. 62:3 (2012), 147–172.
37. Sawaya, G.F., Kulasingam, S., Denberg, T.D., Qaseem, A., Clinical guidelines committee of American college of p. cervical cancer screening in average-risk women: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann. Intern. Med. 162:12 (2015), 851–859.
38. Schwaiger, C.B., Aruda, M.M., LaCoursiere, S., Lynch, K.E., Rubin, R.J., Increasing adherence to cervical cancer screening guidelines. J. Nurs. Pract. 9:8 (2013), 528–535.
39. Schwartz, A.L., Landon, B.E., Elshaug, A.G., Chernew, M.E., McWilliams, J.M., Measuring low-value care in Medicare. JAMA Intern. Med. 174:7 (2014), 1067–1076.
40. Sirovich, B.E., Welch, H.G., Cervical cancer screening among women without a cervix. JAMA 291:24 (2004), 2990–2993.
41. STROBE, Statement strengthening the reporting of observational studies in epidemiology: available checklists: University of Bern. Available from: https://strobe-statement.org/index.php?id=available-checklists, 2007.
42. Summers, S.L., Petzel, A., Anderson, J., Kenton, K., Cervical cancer screening rates in a chart review of adolescent patients at an academic institution before and after the publication of the 2009 American College of Obstetricians and Gynecologists’ recommendations. J. Pediatr. Adolesc. Gynecol. 28:4 (2015), 258–262.
43. Teoh, D.G., Marriott, A.E., Isaksson Vogel, R., Marriott, R.T., Lais, C.W., Downs, L.S. Jr. et al., Adherence to the 2012 national cervical cancer screening guidelines: a pilot study. Am. J. Obstet. Gynecol. 212:1 (2015), 62.e1–62.e9.
44. The American College of Obstertricians and Bynecologists, FAQ cervical cancer screening 2017. Available from https://www.acog.org/Patients/FAQs/Cervical-Cancer-Screening.
45. Tsui, J., Hofstetter, A.M., Soren, K., Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines. Prev. Med. 63 (2014), 81–86.
46. U.S. Preventive Services Task Force, Guide to clinical preventive services: report of the U.S. Preventive Services Task Force, 2d ed., 1996, Williams & Wilkins, Baltimore.
47. U.S. Preventive Services Task Force, Screening for Cervical Cancer: Recommendations and Rationale. 2003, Agency for Healthcare Research and Quality, Rockville, MD Available from https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/cervical-cancer-screening.
48. U.S. Preventive Services Task Force, Final update summary: cervical cancer: screening 2012. Available from https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/cervical-cancer-screening.
49. Verrilli, L., Winer, R.L., Mao, C., Adherence to cervical cancer screening guidelines by gynecologists in the Pacific Northwest. J. Low. Genit. Tract Dis. 18:3 (2014), 228–234.
50. Watson, M., King, J., Ajani, U., Houston, K., Saraiya, M., Cervical cancer screening among women by hysterectomy status and among women aged >65 years - United States. Centers for Disease Control and Prevention MMWR, Morbidity and Mortality Weekly Report Div of Cancer Prevention and Control, Nationsal Center for Chronic Disease Prevention and Health Promotion, CDC; January 4, 2013, 2000–2010.
51. Welch, H.G., Black, W.C., Overdiagnosis in cancer. J. Natl. Cancer Inst. 102:9 (2010), 605–613.
52. Wentzensen, N., [Epidemiology, prevention and early detection of cervical cancer]. Der Onkologe: Organ Der Deutschen Krebsgesellschaft eV., 22(10), 2016, 725–736.
53. White, P., Effects of electronic health record-based interventions on cervical cancer screening in adolescents: a 1-year follow-up. J. Low. Genit. Tract Dis. 18:2 (2014), 169–173.
54. White, P., Kenton, K., Use of electronic medical record-based tools to improve compliance with cervical cancer screening guidelines: effect of an educational intervention on physicians’ practice patterns. J. Low. Genit. Tract Dis. 17:2 (2013), 175–181.
55. World Bank Country and Lending Groups, World bank data help desk. Available from https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-lending-groups.
56. Zaza, S., Wright-De Agüero, L.K., Briss, P.A., Truman, B.I., Hopkins, D.P., Hennessy, M.H. et al., Data collection instrument and procedure for systematic reviews in the guide to community preventive services. Task force on community preventive services. Am. J. Prev. Med. 18:1 Suppl (2000), 44–74.